DE GIGLIO, ANDREA

DE GIGLIO, ANDREA  

DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE  

Assegnisti  

Mostra records
Risultati 1 - 20 di 22 (tempo di esecuzione: 0.039 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
Bilateral radiation recall pneumonitis during immunotherapy for an advanced renal cell carcinoma: A challenging case enhances the need for a multidisciplinary approach De Giglio A.; Scorsetti M.; Franceschini D.; Massari F.; Ardizzoni A. 2021-01-01 EUROPEAN JOURNAL OF CANCER - 1.01 Articolo in rivista -
Challenges in the management of advanced NSCLC among Italian oncologists: a 2019 national survey unfolds regional disparities De Giglio A.; Orlando V.; Andrini E.; Ricciuti B.; Lamberti G.; Chiari R. 2022-01-01 TUMORI - 1.01 Articolo in rivista -
Clinical consideration for choosing combination therapies in advanced non-small-cell lung cancer: Age, Eastern Cooperative Organization performance status 2, steroids and antibiotics de Giglio A.; Nuvola G.; Baldini C. 2020-01-01 FUTURE ONCOLOGY - 1.01 Articolo in rivista -
Comparison of Sequential Testing and Next Generation Sequencing in advanced Lung Adenocarcinoma patients – A single centre experience Dall'Olio F.G.; Conci N.; Rossi G.; Fiorentino M.; De Giglio A.; Grilli G.; Altimari A.; Gruppion...i E.; Filippini D.M.; Di Federico A.; Nuvola G.; Ardizzoni A. 2020-01-01 LUNG CANCER - 1.01 Articolo in rivista -
Dramatic Response to Lorlatinib in a Heavily Pretreated Lung Adenocarcinoma Patient Harboring G1202R Mutation and a Synchronous Novel R1192P ALK Point Mutation Baglivo S.; Ricciuti B.; Ludovini V.; Metro G.; Siggillino A.; De Giglio A.; Chiari R. 2018-01-01 JOURNAL OF THORACIC ONCOLOGY - 1.01 Articolo in rivista -
Durvalumab consolidation in patients with unresectable stage III non-small cell lung cancer with driver genomic alterations Riudavets M.; Auclin E.; Mosteiro M.; Dempsey N.; Majem M.; Lobefaro R.; Lopez-Castro R.; Bosch-B...arrera J.; Pilotto S.; Escalera E.; Tagliamento M.; Mosquera J.; Zalcman G.; Aboubakar-Nana F.; Ponce S.; Dal Maso A.; Spotti M.; Mielgo-Rubio X.; Mussat E.; Reyes R.; Benitez J.-C.; Lupinacci L.; Duchemann B.; De Giglio A.; Blaquier J.; Audigier-Valette C.; Scheffler M.; Nadal E.; Lopes G.; Signorelli D.; Garcia-Campelo R.; Menis J.; Bluthgen V.; Campayo M.; Recondo G.; Besse B.; Planchard D.; Mezquita L. 2022-01-01 EUROPEAN JOURNAL OF CANCER - 1.01 Articolo in rivista -
Fatal acute disseminated intravascular coagulation as presentation of advanced ALK-positive non-small cell lung cancer: Does oncogene addiction matter? De Giglio A.; Porreca R.; Brambilla M.; Metro G.; Prosperi E.; Bellezza G.; Pirro M.; Chiari R.; ...Ricciuti B. 2018-01-01 THROMBOSIS RESEARCH - 1.01 Articolo in rivista -
Immunobiology of thymic epithelial tumors: Implications for immunotherapy with immune checkpoint inhibitors Tateo V.; Manuzzi L.; De Giglio A.; Parisi C.; Lamberti G.; Campana D.; Pantaleo M.A. 2020-01-01 INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - 1.01 Articolo in rivista -
Immunotherapy in Pancreatic Cancer: Why Do We Keep Failing? A Focus on Tumor Immune Microenvironment, Predictive Biomarkers and Treatment Outcomes Di Federico A.; Mosca M.; Pagani R.; Carloni R.; Frega G.; De Giglio A.; Rizzo A.; Ricci D.; Tavo...lari S.; Di Marco M.; Palloni A.; Brandi G. 2022-01-01 CANCERS - 1.01 Articolo in rivista -
Impact of immune-related adverse events on survival in patients with advanced non-small cell lung cancer treated with nivolumab: long-term outcomes from a multi-institutional analysis Ricciuti B.; Genova C.; De Giglio A.; Bassanelli M.; Dal Bello M.G.; Metro G.; Brambilla M.; Bagl...ivo S.; Grossi F.; Chiari R. 2019-01-01 JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY - 1.01 Articolo in rivista -
An overview on molecular characterization of thymic tumors: Old and new targets for clinical advances Tateo V.; Manuzzi L.; Parisi C.; De Giglio A.; Campana D.; Pantaleo M.A.; Lamberti G. 2021-01-01 PHARMACEUTICALS - 1.01 Articolo in rivista pharmaceuticals-14-00316.pdf
PD-(L)1 inhibitors as single-agent or in combination with chemotherapy for advanced, PD-L1-high non-small cell lung cancer: a meta-analysis Di Federico A.; De Giglio A.; Nuvola G.; Deiana C.; Conci N.; Gelsomino F.; Ardizzoni A. 2021-01-01 FUTURE ONCOLOGY - 1.01 Articolo in rivista -
PD-1/PD-L1 inhibitor monotherapy or in combination with chemotherapy as upfront treatment for advanced NSCLC with PD-L1 expression ≥ 50%: Selecting the best strategy Di Federico A.; De Giglio A.; Parisi C.; Gelsomino F.; Ardizzoni A. 2021-01-01 CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY - 1.01 Articolo in rivista -
PD-L1 Expression in Circulating Tumor Cells as a Promising Prognostic Biomarker in Advanced Non–small-cell Lung Cancer Treated with Immune Checkpoint Inhibitors Dall'Olio F.G.; Gelsomino F.; Conci N.; Marcolin L.; De Giglio A.; Grilli G.; Sperandi F.; Fontan...a F.; Terracciano M.; Fragomeno B.; Tober N.; Manferrari G.; Brocchi S.; Golfieri R.; Fiorentino M.; Ardizzoni A. 2021-01-01 CLINICAL LUNG CANCER - 1.01 Articolo in rivista -
Precision medicine against ALK-positive non-small cell lung cancer: beyond crizotinib Ricciuti B.; De Giglio A.; Mecca C.; Arcuri C.; Marini S.; Metro G.; Baglivo S.; Sidoni A.; Belle...zza G.; Crino L.; Chiari R. 2018-01-01 MEDICAL ONCOLOGY - 1.01 Articolo in rivista -
Prognostic relevance of pleural invasion for resected NSCLC patients undergoing adjuvant treatments: A propensity score-matched analysis of SEER database De Giglio A.; Di Federico A.; Gelsomino F.; Ardizzoni A. 2021-01-01 LUNG CANCER - 1.01 Articolo in rivista -
Programmed Cell Death Protein-1 Inhibitors Versus Programmed Death-Ligand 1 Inhibitors in Addition to Chemotherapy for the First-Line Treatment of Advanced NSCLC: A Systematic Review and Meta-Analysis Di Federico A.; De Giglio A.; Parisi C.; Gelsomino F.; Boni L.; Ardizzoni A. 2021-01-01 JTO CLINICAL AND RESEARCH REPORTS - 1.01 Articolo in rivista -
Psychiatric Adverse Reactions to Anaplastic Lymphoma Kinase Inhibitors in Non-Small-Cell Lung Cancer: Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System Sisi, Monia; Fusaroli, Michele; De Giglio, Andrea; Facchinetti, Francesco; Ardizzoni, Andrea; Ras...chi, Emanuel; Gelsomino, Francesco 2022-01-01 TARGETED ONCOLOGY - 1.01 Articolo in rivista Sisi2022_Article_PsychiatricAdverseReactionsToA.pdf11523_2021_865_MOESM1_ESM.pdf
Safety and Efficacy of Nivolumab in Patients With Advanced Non–small-cell Lung Cancer Treated Beyond Progression Ricciuti B.; Genova C.; Bassanelli M.; De Giglio A.; Brambilla M.; Metro G.; Baglivo S.; Dal Bell...o M.G.; Ceribelli A.; Grossi F.; Chiari R. 2019-01-01 CLINICAL LUNG CANCER - 1.01 Articolo in rivista -
Smoking status during first-line immunotherapy and chemotherapy in NSCLC patients: A case–control matched analysis from a large multicenter study Cortellini A.; De Giglio A.; Cannita K.; Cortinovis D.L.; Cornelissen R.; Baldessari C.; Giusti R....; D'Argento E.; Grossi F.; Santoni M.; Catino A.; Berardi R.; Sforza V.; Rossi G.; Antonuzzo L.; Di Noia V.; Signorelli D.; Gelibter A.; Occhipinti M.A.; Follador A.; Rastelli F.; Chiari R.; Gravara L.D.; Inno A.; De Tursi M.; Di Marino P.; Mansueto G.; Zoratto F.; Filetti M.; Montrone M.; Citarella F.; Pensieri M.V.; Russano M.; Cantini L.; Nigro O.; Leonetti A.; Bordi P.; Minuti G.; Landi L.; De Toma A.; Donisi C.; Ricciardi S.; Migliorino M.R.; Napoli V.M.; Leone G.; Metro G.; Banna G.L.; Friedlaender A.; Addeo A.; Ficorella C.; Porzio G. 2021-01-01 THORACIC CANCER - 1.01 Articolo in rivista -